Data Source: IRIS by Real Chemistry | Image Credit: Real Chemistry Medicaid coverage for GLP-1s, both for Type 2 diabetes and obesity, varies widely across the United States
They looked at outcomes that occurred with continued GLP-1 use into the first trimester, comparing them to non-continuation of the medicines
However, certain health conditions, lifestyle factors, and treatment-related side effects may increase the likelihood of stone formation, particularly when hydration levels are not maintained
The company recently announced a GLP-1 program that had Wall Street buzzing, as some analysts think the move makes the stock more attractive
novoMEDLINK FDA-reflected update reported in 2023
She notes that she and other authors will continue to investigate the mechanisms behind semaglutides beneficial cardiovascular effects